Qiqi Pharmaceutical was established in October 2016 and is located in Zhuji, Zhejiang Province—the hometown of the famous ancient beauty Xishi. With a registered capital of 50 million yuan and more than 70 employees, it is a wholly-owned subsidiary of Anqing Huiyinbi Pharmaceutical Co., Ltd., one of China’s production bases for gynecological drugs, and a National High-Tech Enterprise. It has also established a provincial-level research and development center for high-tech enterprises.

Adhering to technological innovation, the company takes "developing characteristics through traditional Chinese medicine (TCM) and pursuing benefits through new drugs" as its product development strategy, and has formed a serialized product pattern and characteristics of TCM for gynecology. Currently, it has 6 production lines for dosage forms including tablets, capsules (including cephalosporins), granules, mixtures, and lotions, covering a total of 23 product varieties. Among them, the gynecological product series includes Huiyinbi Yunkang Oral Liquid, Baijie Lotion, Guishao Tiaojing Capsules, Gengnian’an Capsules, Yuanhu Zhitong Granules, and Shu’er Lotion; additionally, Ganyu Shu Granules is under research and development.

The company’s flagship product, Huiyinbi Yunkang Oral Liquid, is a National Class III New Drug, a National Key New Product, a Zhejiang Provincial Famous Product, and a product included in the National Medical Insurance Catalog. It has obtained the Zhejiang Provincial New Product Achievement Appraisal Certificate and the title of "2017 National TCM Ingenuity Product". The sugar-free version with easy-break bottle packaging is exclusively produced by the company. It is mainly used for the treatment of threatened abortion and habitual abortion, and has been highly recognized and affirmed by experts such as Professor Xiao Chengcong—a leading authority in gynecology in China. Experts believe that Huiyinbi Yunkang Oral Liquid has a reasonable formula and high safety, and its application can be further expanded to scenarios such as pre-implantation and post-implantation medication for in vitro fertilization (IVF), as well as improving ovarian function in elderly women preparing for a second child.

Baijie Lotion, another product of the company, is a National Class III New Drug and a pure TCM gynecological lotion. It has the effects of clearing heat and detoxifying, drying dampness and killing parasites, relieving itching, and eliminating leukorrhea. It makes up for the limitations of ordinary TCM lotions (such as narrow application scope) and the defects of western medicine lotions (such as treating symptoms but not the root cause, high recurrence rate, and high toxicity). As a Zhejiang Provincial High-Tech Product, it holds a national invention patent.

Huiyinbi Humei Buccal Tablets is a National TCM New Drug. It has the effects of dispelling wind and clearing heat, detoxifying and relieving sore throat, and promoting the production of body fluid to quench thirst. Containing natural antibacterial ingredients, it has obvious bacteriostatic effects—thus no need for combined use with antibiotics, which can effectively avoid the harms caused by antibiotics. Meanwhile, it has three unique flavors to meet the needs of people with different taste preferences, giving it incomparable advantages over other similar products.

Qiqi Pharmaceutical will unswervingly develop the characteristics of its TCM gynecological product series, with a focus on key varieties such as Huiyinbi Yunkang Oral Liquid and Baijie Lotion. It will strengthen and refine its products in the gynecological field, always adhering to the business philosophy of "wholeheartedly producing high-quality medicines", fulfilling its social responsibilities, and contributing to the cause of human health.